Table 4 Multivariate analysis using binary logistic regression

WtHR > 0.50

2.65 (2.47–2.84) < 0.0001

1.01 (0.86–1.20) 0.867

1.14 (1.04–1.26) 0.007

0.95 (0.89–1.02) 0.185

Obesity BMI

1.37 (1.27–1.48) < 0.0001

1.05 (0.88–1.27) 0.582

1.18 (1.06–1.31) 0.003

0.92 (0.85–0.99) 0.049

Obesity CUN BAE

0.97 (0.89–1.07) 0.585

1.11 (0.89–1.38) 0.359

1.06 (0.93–1.20) 0.394

0.87 (0.79–0.95) 0.003

Obesity ECORE-BF

1.21 (1.11–1.32) < 0.0001

1.07 (0.87–1.32) 0.522

1.07 (0.95–1.21) 0.242

0.87 (0.79–0.95) 0.003

Obesity RFM

0.56 (0.52–0.60) < 0.0001

0.97 (0.82–1.14) 0.676

1.20 (1.10–1.32) < 0.0001

0.93 (0.87–0.99) 0.048

Obesity Palafolls

2.15 (1.90–2.43) < 0.0001

1.06 (0.79–1.43) 0.684

1.10 (0.93–1.30) 0.278

0.86 (0.76–0.98) 0.026

Diabesity

1.86 (1.65–2.10) < 0.0001

0.83 (0.62–1.11) 0.204

1.69 (1.42–2.02) < 0.0001

0.98 (0.87–1.10) 0.712

Hypertension

1.84 (1.72–1.97) < 0.0001

1.09 (0.92–1.28) 0.316

1.21 (1.11–1.33) < 0.0001

0.99 (0.93–1.07) 0.838

Total cholesterol high

0.53 (0.50–0.57) < 0.0001

0.94 (0.80–1.10) 0.431

0.96 (0.87–1.05) 0.335

0.92 (0.86–0.99) 0.019

LDL-c high

0.63 (0.59–0.67) < 0.0001

0.95 (0.81–1.11) 0.523

1.04 (0.95–1.14) 0.370

0.93 (0.87–0.99) 0.045

Triglycerides high

2.42 (2.23–2.63) < 0.0001

0.94 (0.79–1.13) 0.519

0.95 (0.86–1.06) 0.350

0.97 (0.90–1.05) 0.469

Diabetes

1.97 (1.82–2.14) < 0.0001

0.74 (0.61–0.90) 0.002

1.78 (1.58–2.00) < 0.0001

1.03 (0.95–1.12) 0.446

MS NCEP-ATPIII criteria

1.67 (1.55–1.79) < 0.0001

0.84 (0.71–0.99) 0.040

1.26 (1.14–1.39) < 0.0001

0.99 (0.93–1.07) 0.906

MS IDF criteria

0.97 (0.89–1.05) 0.429

0.92 (0.76–1.11) 0.374

1.02 (0.91–1.15) 0.690

1.01 (0.93–1.10) 0.808

MS JIS criteria

2.69 (2.51–2.88) < 0.0001

0.84 (0.71–0.99) 0.035

1.30 (1.18–1.43) < 0.0001

0.97 (0.91–1.05) 0.468

Atherogenic dyslipidemia

1.55 (1.40–1.72) < 0.0001

0.96 (0.76–1.20) 0.703

0.98 (0.86–1.12) 0.730

1.01 (0.91–1.11) 0.925

Lipid triad

1.41 (1.18–1.69) < 0.0001

0.87 (0.58–1.31) 0.498

1.12 (0.88–1.43) 0.361

0.96 (0.81–1.16) 0.692

Hypertriglyceridemic waist

1.41 (1.18–1.69) < 0.0001

0.87 (0.58–1.31) 0.498

1.12 (0.88–1.43) 0.361

0.96 (0.81–1.16) 0.692

AI CT/HDL-c moderate-high

1.09 (1.01–1.17) 0.023

0.93 (0.78–1.10) 0.382

1.18 (1.07–1.31) 0.001

0.93 (0.86–0.99) 0.048

AI triglycerides/HDL-c high

3.83 (3.53–4.16) < 0.0001

1.02 (0.86–1.21) 0.834

0.95 (0.86–1.05) 0.276

0.96 (0.87–1.05) 0.264

AI LDL-c/HDL-c high

1.66 (1.55–1.78) < 0.0001

0.97 (0.82–1.14) 0.695

1.22 (1.11–1.34) < 0.0001

0.97 (0.90–1.04) 0.335

REGICOR scale high-very high

1.97 (1.64–2.36) < 0.0001

0.90 (0.61–1.33) 0.595

1.28 (1.00–1.63) 0.049

3.15 (2.69–3.69) < 0.0001

SCORE scale high-very high

22.51 (19.87–25.49) < 0.0001

0.98 (0.80–1.21) 0.873

1.18 (1.05–1.32) 0.007

17.88 (15.80–20.24) < 0.0001

Fatty liver index high risk high

4.06 (3.66–4.50) < 0.0001

0.84 (0.68–1.04) 0.107

1.06 (0.93–1.20) 0.380

0.95 (0.87–1.04) 0.227

Fatty liver disease index high

1.36 (1.15–1.62 < 0.0001

1.44 (1.00–2.07) 0.048

0.82 (0.64–1.04) 0.106

1.04 (0.87–1.24) 0.673

Bard scoring system high

2.10 (1.95–2.26) < 0.0001

0.92 (0.77–1.11) 0.397

1.24 (1.12–1.38) < 0.0001

1.00 (0.93–1.09) 0.925

Lipid accumulation product high

1.69 (1.58–1.81) < 0.0001

1.05 (0.89–1.23) 0.561

0.84 (0.76–0.92) < 0.0001

0.94 (0.87–1.01) 0.076